Exponent (EXPO) Financials

$56.99 -0.36 (-0.63%)

Closing price 04:00 PM Eastern

Extended Trading

$57.01 +0.02 (+0.04%)

As of 04:10 PM Eastern

Annual Income Statements for Exponent

This table shows Exponent's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025	1/2/2026
Net Income / (Loss) Attributable to Common Shareholders	44	47	41	72	82	83	101	102	100	109	106
Consolidated Net Income / (Loss)	44	47	41	72	82	83	101	102	100	109	106
Net Income / (Loss) Continuing Operations	44	47	41	72	82	83	101	102	100	109	106
Total Pre-Tax Income	71	69	83	93	104	97	126	132	136	147	147
Total Operating Income	69	62	72	91	85	83	109	141	111	120	120
Total Gross Profit	128	122	138	164	165	150	188	249	217	229	240
Total Revenue	313	315	348	380	417	400	466	513	537	559	582
Operating Revenue	313	315	348	380	417	400	466	513	537	559	582
Total Cost of Revenue	185	193	210	215	252	250	278	264	320	330	342
Operating Cost of Revenue	185	193	210	215	252	250	278	264	320	330	342
Total Operating Expenses	59	60	65	73	80	67	79	108	106	109	120
Selling, General & Admin Expense	42	44	47	48	54	45	48	59	66	69	75
Other Operating Expenses / (Income)	17	16	18	25	26	21	31	49	40	40	45
Total Other Income / (Expense), net	2.20	7.21	10	1.86	19	14	17	-8.61	25	28	28
Interest & Investment Income	0.21	0.68	1.29	2.75	3.91	1.71	0.07	2.10	7.15	10	9.31
Other Income / (Expense), net	1.99	6.53	9.16	-0.89	15	12	17	-11	17	18	18
Income Tax Expense	28	22	41	21	22	14	25	30	36	38	41
Basic Earnings per Share	$1.64	$0.90	$0.78	$1.37	$1.56	$1.58	$1.92	$1.98	$1.96	$2.13	$2.08
Weighted Average Basic Shares Outstanding	26.61M	52.98M	52.72M	52.91M	52.69M	52.39M	52.61M	51.73M	51.15M	51.13M	50.90M
Diluted Earnings per Share	$1.60	$0.87	$0.77	$1.33	$1.53	$1.55	$1.90	$1.96	$1.94	$2.11	$2.07
Weighted Average Diluted Shares Outstanding	27.30M	54.33M	53.97M	54.17M	53.88M	53.32M	53.33M	52.28M	51.64M	51.57M	51.24M
Weighted Average Basic & Diluted Shares Outstanding	26.60M	26.50M	53M	52.70M	51.82M	51.80M	52.12M	50.64M	50.56M	50.82M	49.25M
Cash Dividends to Common per Share	$0.60	$0.36	$0.42	$0.52	$0.64	$0.76	$0.80	$0.96	$1.04	$1.12	$1.20

This table shows Exponent's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/29/2023	12/29/2023	3/29/2024	6/28/2024	9/27/2024	1/3/2025	4/4/2025	7/4/2025	10/3/2025	1/2/2026	4/3/2026
Net Income / (Loss) Attributable to Common Shareholders	25	21	30	29	26	24	27	27	28	25	30
Consolidated Net Income / (Loss)	25	21	30	29	26	24	27	27	28	25	30
Net Income / (Loss) Continuing Operations	25	21	30	29	26	24	27	27	28	25	30
Total Pre-Tax Income	34	30	40	40	36	31	38	37	39	34	42
Total Operating Income	34	18	31	36	26	27	44	17	29	29	41
Total Gross Profit	59	44	55	61	54	59	70	44	59	67	75
Total Revenue	133	123	145	141	136	137	146	142	147	147	166
Operating Revenue	133	123	145	141	136	137	146	142	147	147	166
Total Cost of Revenue	74	79	90	79	82	78	76	97	88	81	91
Operating Cost of Revenue	74	79	90	79	82	78	76	97	88	81	91
Total Operating Expenses	25	26	24	25	28	31	25	27	30	37	34
Selling, General & Admin Expense	17	17	16	17	17	18	17	18	20	19	19
Other Operating Expenses / (Income)	8.38	9.03	7.73	8.10	11	13	8.07	9.09	10	18	14
Total Other Income / (Expense), net	0.08	12	9.71	3.94	10	4.08	-6.67	20	9.58	4.97	0.96
Interest & Investment Income	1.86	1.93	2.63	2.23	2.56	2.59	2.71	2.34	2.31	1.94	1.72
Other Income / (Expense), net	-1.77	9.77	7.08	1.71	7.53	1.49	-9.39	17	7.27	3.03	-0.76
Income Tax Expense	9.48	9.16	10	10	9.89	7.74	11	10	11	9.34	13
Basic Earnings per Share	$0.48	$0.41	$0.59	$0.57	$0.51	$0.46	$0.52	$0.52	$0.55	$0.49	$0.59
Weighted Average Basic Shares Outstanding	51.20M	51.15M	51.01M	51.11M	51.18M	51.13M	51.28M	51.19M	50.87M	50.90M	49.79M
Diluted Earnings per Share	$0.48	$0.40	$0.59	$0.57	$0.50	$0.45	$0.52	$0.52	$0.55	$0.48	$0.59
Weighted Average Diluted Shares Outstanding	51.65M	51.64M	51.42M	51.52M	51.62M	51.57M	51.65M	51.50M	51.18M	51.24M	50.12M
Weighted Average Basic & Diluted Shares Outstanding	50.62M	50.56M	50.67M	50.73M	50.76M	50.82M	50.75M	50.50M	49.89M	49.25M	48.51M
Cash Dividends to Common per Share	$0.26	$0.26	$0.28	$0.28	$0.28	$0.28	$0.30	$0.30	$0.30	$0.30	$0.31

This table details how cash moves in and out of Exponent's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025	1/2/2026
Net Change in Cash & Equivalents	-3.74	-11	9.83	2.27	49	21	100	-136	26	72	-37
Net Cash From Operating Activities	60	67	68	91	108	103	125	94	127	145	132
Net Cash From Continuing Operating Activities	60	67	68	91	108	103	125	94	127	145	132
Net Income / (Loss) Continuing Operations	44	47	41	72	82	83	101	102	100	109	106
Consolidated Net Income / (Loss)	44	47	41	72	82	83	101	102	100	109	106
Depreciation Expense	5.48	6.13	6.29	6.29	6.81	6.87	6.49	7.08	8.92	9.69	10
Amortization Expense	0.60	0.00	0.00	-0.11	-0.52	-0.16	-0.01	0.00	0.00	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	7.49	16	18	19	20	19	21	23	24	28	27
Changes in Operating Assets and Liabilities, net	3.32	-2.45	1.95	-6.26	-0.38	-5.08	-4.33	-39	-5.49	-1.84	-11
Net Cash From Investing Activities	-27	-27	-18	-26	4.27	5.02	38	-12	-16	-6.94	-9.39
Net Cash From Continuing Investing Activities	-27	-27	-18	-26	4.27	5.02	38	-12	-16	-6.94	-9.39
Purchase of Property, Plant & Equipment	-5.38	-14	-4.73	-16	-23	-4.99	-6.83	-12	-16	-6.94	-9.39
Purchase of Investments	-44	-51	-29	-53	-39	-40	-35	0.00	0.00	0.00	0.00
Sale and/or Maturity of Investments	22	38	16	43	66	50	80	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	-37	-49	-41	-63	-63	-88	-63	-216	-86	-65	-160
Net Cash From Continuing Financing Activities	-37	-49	-41	-63	-63	-88	-63	-216	-86	-65	-160
Repurchase of Common Equity	-23	-24	-12	-28	-22	-40	-7.00	-156	-24	-5.71	-97
Payment of Dividends	-16	-19	-22	-27	-34	-40	-43	-49	-54	-58	-62
Issuance of Common Equity	3.01	1.76	2.03	1.47	3.23	6.73	3.11	2.02	2.18	5.74	2.37
Other Financing Activities, net	-0.97	-7.69	-9.52	-8.84	-11	-15	-16	-13	-9.94	-6.92	-4.17
Effect of Exchange Rate Changes	-0.28	-1.12	0.97	-0.60	0.46	1.11	0.17	-2.02	0.71	-0.74	1.12

This table details how cash moves in and out of Exponent's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/29/2023	12/29/2023	3/29/2024	6/28/2024	9/27/2024	1/3/2025	4/4/2025	7/4/2025	10/3/2025	1/2/2026	4/3/2026
Net Change in Cash & Equivalents	-11	50	-18	35	16	39	-14	-13	-24	15	-103
Net Cash From Operating Activities	22	71	10	48	30	56	7.27	36	33	56	-0.98
Net Cash From Continuing Operating Activities	22	71	10	48	30	56	7.27	36	33	56	-0.98
Net Income / (Loss) Continuing Operations	25	21	30	29	26	24	27	27	28	25	30
Consolidated Net Income / (Loss)	25	21	30	29	26	24	27	27	28	25	30
Depreciation Expense	2.36	2.38	2.32	2.49	2.39	2.49	2.49	2.52	2.53	2.54	2.52
Non-Cash Adjustments To Reconcile Net Income	5.52	4.49	8.62	6.66	6.25	6.17	8.44	5.58	6.85	5.92	9.33
Changes in Operating Assets and Liabilities, net	-10	44	-31	9.97	-4.97	24	-30	1.57	-4.78	22	-42
Net Cash From Investing Activities	-3.31	-1.93	-1.48	-1.15	-1.71	-2.60	-1.75	-2.27	-2.68	-2.69	-2.45
Net Cash From Continuing Investing Activities	-3.31	-1.93	-1.48	-1.15	-1.71	-2.60	-1.75	-2.27	-2.68	-2.69	-2.45
Purchase of Property, Plant & Equipment	-3.31	-1.93	-1.48	-1.15	-1.71	-2.60	-1.75	-2.27	-2.68	-2.69	-2.45
Net Cash From Financing Activities	-30	-20	-27	-13	-13	-12	-20	-47	-55	-38	-100
Net Cash From Continuing Financing Activities	-30	-20	-27	-13	-13	-12	-20	-47	-55	-38	-100
Repurchase of Common Equity	-17	-7.24	-5.47	-0.24	0.00	-0.00	0.00	-33	-40	-24	-79
Payment of Dividends	-13	-13	-16	-14	-14	-14	-16	-15	-15	-15	-17
Issuance of Common Equity	0.57	0.37	0.62	1.84	1.29	2.00	0.48	0.43	0.60	0.87	0.78
Other Financing Activities, net	-	-0.02	-6.80	-	-0.03	-0.09	-4.17	-	-	-	-5.11
Effect of Exchange Rate Changes	-0.39	0.71	-0.21	0.01	1.41	-1.94	0.74	0.21	0.11	0.06	-0.27

This table presents Exponent's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025	1/2/2026
Total Assets	388	404	440	469	563	580	684	587	647	777	778
Total Current Assets	273	274	316	327	364	367	453	349	380	447	428
Cash & Equivalents	126	115	125	127	176	198	298	161	187	259	222
Accounts Receivable	89	87	110	106	120	112	140	170	167	161	182
Prepaid Expenses	13	13	9.01	12	12	13	15	18	25	27	24
Plant, Property, & Equipment, net	28	37	35	46	62	60	60	66	75	73	72
Total Noncurrent Assets	86	93	89	96	138	153	171	172	192	257	278
Goodwill	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61
Noncurrent Deferred & Refundable Income Taxes	39	42	30	34	37	41	47	54	54	57	67
Other Noncurrent Operating Assets	1.65	1.06	1.35	54	92	104	116	109	129	192	202
Total Liabilities & Shareholders' Equity	388	404	440	469	563	580	684	587	647	777	778
Total Liabilities	125	130	151	155	213	219	267	266	291	356	387
Total Current Liabilities	80	80	93	98	124	117	153	159	162	163	178
Accounts Payable	11	10	15	12	19	16	25	29	22	22	31
Current Deferred Revenue	7.80	7.62	8.30	9.17	13	12	20	19	22	16	19
Current Employee Benefit Liabilities	62	63	70	77	87	83	104	106	112	119	121
Other Current Liabilities	-	-	-	0.00	5.94	5.99	5.16	5.26	6.30	5.39	6.89
Total Noncurrent Liabilities	44	50	57	57	89	101	114	107	129	193	209
Noncurrent Employee Benefit Liabilities	40	47	53	53	68	84	101	91	103	113	129
Other Noncurrent Operating Liabilities	1.91	2.01	3.33	2.55	21	2.99	13	16	25	80	81
Total Equity & Noncontrolling Interests	263	273	289	314	350	361	417	321	356	421	390
Total Preferred & Common Equity	263	273	289	314	350	361	417	321	356	421	390
Total Common Equity	263	273	289	311	348	360	417	321	356	421	390
Common Stock	180	195	210	227	245	265	281	301	322	346	370
Retained Earnings	269	291	304	342	385	422	478	529	574	624	668
Treasury Stock	-184	-209	-223	-253	-278	-324	-341	-506	-537	-545	-646
Accumulated Other Comprehensive Income / (Loss)	-1.81	-3.13	-2.03	-5.71	-3.52	-3.86	-1.98	-3.59	-2.98	-3.79	-2.29

This table presents Exponent's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/29/2023	3/29/2024	6/28/2024	9/27/2024	4/4/2025	7/4/2025	10/3/2025	4/3/2026
Total Assets	559	566	604	602	629	709	744	763	759	761	687
Total Current Assets	333	318	345	343	352	391	413	433	426	417	341
Cash & Equivalents	148	126	148	137	169	203	220	245	232	207	119
Accounts Receivable	166	173	176	182	163	166	169	167	171	182	197
Prepaid Expenses	18	20	21	24	21	22	24	21	23	27	25
Plant, Property, & Equipment, net	64	69	77	76	75	73	73	72	72	72	72
Total Noncurrent Assets	162	179	183	183	203	245	259	259	262	272	275
Goodwill	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61
Noncurrent Deferred & Refundable Income Taxes	51	52	52	54	52	52	54	60	60	63	64
Other Noncurrent Operating Assets	103	118	122	120	142	185	196	190	193	201	202
Total Liabilities & Shareholders' Equity	559	566	604	602	629	709	744	763	759	761	687
Total Liabilities	239	225	247	249	255	316	334	322	332	359	349
Total Current Liabilities	138	109	125	130	114	132	138	130	135	155	142
Accounts Payable	32	26	20	20	24	22	23	37	25	26	37
Current Deferred Revenue	16	15	11	10	16	14	13	14	12	13	16
Current Employee Benefit Liabilities	85	63	88	94	68	91	97	74	92	109	83
Other Current Liabilities	5.36	4.90	5.75	5.70	5.81	4.90	4.94	5.63	5.85	6.49	6.72
Total Noncurrent Liabilities	101	115	123	119	141	184	196	192	197	204	207
Noncurrent Employee Benefit Liabilities	85	101	96	93	116	109	116	112	118	123	128
Other Noncurrent Operating Liabilities	16	14	26	26	25	76	81	80	79	81	79
Total Equity & Noncontrolling Interests	320	342	357	354	374	393	410	441	428	403	338
Total Preferred & Common Equity	320	342	357	354	374	393	410	441	428	403	338
Total Common Equity	320	342	357	354	374	393	410	441	428	403	338
Common Stock	299	315	317	320	335	339	342	362	364	367	386
Retained Earnings	519	543	555	567	589	603	615	635	646	659	682
Treasury Stock	-492	-513	-512	-529	-546	-546	-545	-553	-580	-621	-728
Accumulated Other Comprehensive Income / (Loss)	-5.14	-3.13	-3.26	-3.78	-3.19	-3.17	-1.61	-2.85	-2.49	-2.40	-2.57

This table displays calculated financial ratios and metrics derived from Exponent's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025	1/2/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	49,887,226.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	49,887,226.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2.13
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	42	43	36	71	67	71	88	109	82	88	86
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	33.98%	23.08%	21.00%	22.09%
Earnings before Interest and Taxes (EBIT)	71	68	81	91	100	95	126	130	129	137	138
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	77	75	88	97	107	102	132	137	138	147	148
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	41	34	43	58	54	56	102	69	73	95	80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	91	100	93	105	119	133	119	159	169	162	168
Increase / (Decrease) in Invested Capital	1.33	8.41	-6.93	13	13	15	-14	40	9.64	-6.77	6.24
Book Value per Share	$10.21	$10.68	$11.20	$5.98	$6.72	$6.96	$8.00	$6.33	$7.03	$8.29	$7.82
Tangible Book Value per Share	$9.87	$10.34	$10.87	$5.82	$6.56	$6.80	$7.84	$6.16	$6.86	$8.13	$7.65
Total Capital	263	273	289	314	350	376	417	321	356	421	390
Total Debt	0.00	0.00	0.00	0.00	0.00	14	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	14	0.00	0.00	0.00	0.00	0.00
Net Debt	-172	-174	-196	-209	-232	-228	-298	-161	-187	-259	-222
Capital Expenditures (CapEx)	5.38	14	4.73	16	23	4.99	6.83	12	16	6.94	9.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	21	20	26	20	8.48	7.00	2.09	29	30	25	28
Debt-free Net Working Capital (DFNWC)	192	194	222	228	240	250	300	190	218	284	250
Net Working Capital (NWC)	192	194	222	228	240	250	300	190	218	284	250
Net Nonoperating Expense (NNE)	-1.35	-4.95	-5.24	-1.44	-15	-12	-14	6.66	-18	-21	-20
Net Nonoperating Obligations (NNO)	-172	-174	-196	-209	-232	-228	-298	-161	-187	-259	-222
Total Depreciation and Amortization (D&A)	6.07	6.13	6.29	6.18	6.29	6.71	6.48	7.08	8.92	9.69	10
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$1.56	$1.58	$1.92	$1.98	$1.96	$2.13	$2.08
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	0.00	52.69M	52.39M	52.61M	51.73M	51.15M	51.13M	50.90M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$1.53	$1.55	$1.90	$1.96	$1.94	$2.11	$2.07
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	0.00	53.88M	53.32M	53.33M	52.28M	51.64M	51.57M	51.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	51.82M	51.80M	52.12M	50.64M	50.56M	50.82M	49.25M
Normalized Net Operating Profit after Tax (NOPAT)	42	43	36	71	67	71	88	109	82	88	86
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Exponent's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/29/2023	12/29/2023	3/29/2024	6/28/2024	9/27/2024	1/3/2025	4/4/2025	7/4/2025	10/3/2025	1/2/2026	4/3/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	49,887,226.00	49,254,339.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	49,887,226.00	49,254,339.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.50	0.60
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.84%	-3.50%	3.30%	0.22%	2.21%	11.28%	0.40%	1.01%	7.96%	-	14.29%
EBITDA Growth	-0.12%	-1.84%	12.21%	8.39%	3.61%	2.27%	-6.44%	-7.38%	8.58%	-	14.91%
EBIT Growth	-2.07%	-3.75%	11.93%	8.05%	3.79%	2.07%	-7.28%	-7.96%	8.77%	-	15.91%
NOPAT Growth	-8.93%	-21.32%	-4.03%	24.08%	-23.47%	60.38%	36.93%	-52.94%	12.58%	-	-7.85%
Net Income Growth	0.39%	-7.08%	3.50%	13.51%	6.14%	12.71%	-11.59%	-9.15%	7.68%	-	10.95%
EPS Growth	2.13%	-9.09%	5.36%	14.00%	4.17%	12.50%	-11.86%	-8.77%	10.00%	-	13.46%
Operating Cash Flow Growth	-24.54%	75.77%	255.63%	19.22%	33.84%	-21.40%	-30.27%	-25.07%	9.89%	-	-113.40%
Free Cash Flow Firm Growth	-225.95%	113.33%	464.73%	386.37%	315.93%	765.28%	21.66%	-85.94%	-63.82%	-	-86.71%
Invested Capital Growth	26.37%	6.05%	-4.88%	-9.07%	-11.99%	-4.01%	-4.55%	3.17%	2.58%	-	11.97%
Revenue Q/Q Growth	-4.91%	-7.83%	17.93%	-3.03%	-3.03%	0.36%	6.39%	-2.44%	3.63%	-	12.81%
EBITDA Q/Q Growth	-6.31%	-11.53%	31.37%	-0.46%	-10.44%	-12.68%	20.19%	-1.46%	4.99%	-	24.29%
EBIT Q/Q Growth	-7.22%	-12.44%	34.23%	-0.92%	-10.88%	-13.89%	21.93%	-1.64%	5.32%	-	26.28%
NOPAT Q/Q Growth	15.36%	-47.73%	78.99%	14.96%	-28.85%	9.55%	52.82%	-60.49%	70.21%	-	36.59%
Net Income Q/Q Growth	-4.70%	-14.71%	44.02%	-3.04%	-10.89%	-9.43%	12.98%	-0.36%	5.62%	-	19.41%
EPS Q/Q Growth	-4.00%	-16.67%	47.50%	-3.39%	-12.28%	-10.00%	15.56%	0.00%	5.77%	-	22.92%
Operating Cash Flow Q/Q Growth	-45.24%	221.20%	-85.37%	363.37%	-38.53%	88.64%	-87.02%	397.97%	-9.86%	-	-101.75%
Free Cash Flow Firm Q/Q Growth	-30.92%	115.23%	961.05%	35.32%	-1.28%	-38.95%	49.18%	-84.37%	154.09%	-	-63.73%
Invested Capital Q/Q Growth	3.65%	-21.98%	21.73%	-7.63%	0.32%	-14.90%	21.05%	-0.16%	-0.25%	-	30.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.49%	35.84%	37.68%	43.46%	39.86%	42.78%	47.84%	31.34%	40.37%	-	45.03%
EBITDA Margin	25.89%	24.85%	27.68%	28.42%	26.25%	22.84%	25.80%	26.06%	26.40%	-	25.94%
Operating Margin	25.45%	14.97%	21.19%	25.43%	18.97%	19.93%	30.54%	12.10%	19.74%	-	24.88%
EBIT Margin	24.12%	22.91%	26.08%	26.65%	24.49%	21.02%	24.09%	24.28%	24.68%	-	24.43%
Profit (Net Income) Margin	18.40%	17.03%	20.80%	20.80%	19.11%	17.25%	18.32%	18.70%	19.06%	-	17.78%
Tax Burden Percent	72.13%	69.56%	74.57%	73.65%	72.47%	75.30%	70.58%	72.13%	72.62%	-	69.84%
Interest Burden Percent	105.78%	106.85%	106.95%	105.96%	107.67%	108.99%	107.74%	106.80%	106.37%	-	104.23%
Effective Tax Rate	27.87%	30.44%	25.43%	26.35%	27.53%	24.70%	29.42%	27.87%	27.38%	-	30.16%
Return on Invested Capital (ROIC)	51.23%	34.05%	40.56%	50.88%	36.78%	50.62%	59.96%	25.35%	42.43%	-	50.35%
ROIC Less NNEP Spread (ROIC-NNEP)	51.19%	29.38%	35.64%	49.23%	32.68%	49.24%	62.23%	18.84%	39.17%	-	49.98%
Return on Net Nonoperating Assets (RNNOA)	-21.70%	-15.13%	-14.65%	-23.06%	-15.26%	-28.26%	-31.57%	-9.98%	-20.57%	-	-23.31%
Return on Equity (ROE)	29.53%	18.92%	25.91%	27.82%	21.51%	22.36%	28.39%	15.37%	21.85%	-	27.04%
Cash Return on Invested Capital (CROIC)	21.03%	44.21%	43.55%	52.80%	52.33%	57.50%	53.01%	39.98%	41.76%	-	28.95%
Operating Return on Assets (OROA)	22.48%	19.94%	23.61%	21.98%	19.81%	16.49%	19.34%	18.54%	18.73%	-	20.30%
Return on Assets (ROA)	17.15%	14.82%	18.83%	17.15%	15.46%	13.53%	14.71%	14.28%	14.47%	-	14.78%
Return on Common Equity (ROCE)	29.53%	18.92%	25.91%	27.82%	21.51%	22.36%	28.39%	15.37%	21.85%	-	27.04%
Return on Equity Simple (ROE_SIMPLE)	28.82%	0.00%	27.08%	26.66%	25.92%	0.00%	23.90%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	24	13	23	26	19	21	31	12	21	21	29
NOPAT Margin	18.36%	10.41%	15.80%	18.73%	13.75%	15.00%	21.55%	8.73%	14.33%	-	17.38%
Net Nonoperating Expense Percent (NNEP)	0.04%	4.67%	4.92%	1.65%	4.10%	1.38%	-2.28%	6.51%	3.26%	-	0.37%
Return On Investment Capital (ROIC_SIMPLE)	-	3.59%	-	-	-	4.87%	7.10%	2.90%	5.23%	5.42%	8.54%
Cost of Revenue to Revenue	55.51%	64.16%	62.32%	56.54%	60.14%	57.22%	52.16%	68.66%	59.63%	-	54.97%
SG&A Expenses to Revenue	12.76%	13.52%	11.15%	12.26%	12.68%	13.34%	11.75%	12.83%	13.80%	-	11.44%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Operating Expenses to Revenue	19.04%	20.87%	16.49%	18.02%	20.90%	22.85%	17.30%	19.24%	20.63%	-	20.15%
Earnings before Interest and Taxes (EBIT)	32	28	38	37	33	29	35	34	36	32	41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	35	31	40	40	36	31	38	37	39	35	43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	12.16	12.37	11.15	12.26	14.00	10.72	8.87	9.15	8.41	-	9.69
Price to Tangible Book Value (P/TBV)	12.46	12.67	11.41	12.53	14.30	10.94	9.05	9.34	8.60	-	9.94
Price to Revenue (P/Rev)	7.94	8.20	7.71	8.90	10.55	8.08	7.00	6.98	5.93	-	5.44
Price to Earnings (P/E)	42.18	43.89	41.18	45.97	54.03	41.41	37.12	38.05	32.32	-	30.10
Dividend Yield	1.21%	1.20%	1.29%	1.14%	0.97%	1.26%	1.48%	1.50%	1.76%	-	1.82%
Earnings Yield	2.37%	2.28%	2.43%	2.18%	1.85%	2.42%	2.69%	2.63%	3.09%	-	3.32%
Enterprise Value to Invested Capital (EV/IC)	19.22	24.96	19.48	24.30	29.00	26.24	18.70	18.78	16.27	-	14.38
Enterprise Value to Revenue (EV/Rev)	7.69	7.86	7.40	8.52	10.15	7.62	6.57	6.57	5.57	-	5.24
Enterprise Value to EBITDA (EV/EBITDA)	30.11	30.63	28.20	31.81	37.75	28.93	25.41	26.01	22.00	-	20.56
Enterprise Value to EBIT (EV/EBIT)	32.06	32.75	30.16	34.05	40.40	30.97	27.27	27.96	23.64	-	22.01
Enterprise Value to NOPAT (EV/NOPAT)	48.43	51.30	49.27	53.46	68.59	48.11	37.78	44.26	37.20	-	37.74
Enterprise Value to Operating Cash Flow (EV/OCF)	43.09	33.11	27.72	30.32	34.58	29.44	25.97	28.48	24.06	-	25.59
Enterprise Value to Free Cash Flow (EV/FCFF)	102.07	58.12	43.60	43.84	51.87	44.69	34.46	47.72	39.46	-	52.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Financial Leverage	-0.42	-0.52	-0.41	-0.47	-0.47	-0.57	-0.51	-0.53	-0.53	-	-0.47
Leverage Ratio	1.72	1.82	1.67	1.75	1.76	1.83	1.71	1.79	1.85	-	1.86
Compound Leverage Factor	1.82	1.95	1.79	1.85	1.90	2.00	1.84	1.91	1.97	-	1.94
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Altman Z-Score	13.18	11.71	12.64	11.72	12.81	10.01	9.83	9.62	8.20	-	8.44
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.65	2.34	3.09	2.97	3.00	2.74	3.32	3.15	2.69	-	2.40
Quick Ratio	2.46	2.19	2.91	2.80	2.82	2.58	3.16	2.98	2.52	-	2.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-21	3.15	33	45	45	27	41	6.36	16	15	5.41
Operating Cash Flow to CapEx	671.54%	3,687.13%	703.91%	4,218.06%	1,733.61%	2,158.34%	414.71%	1,592.88%	1,220.64%	-	-39.75%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	0.87	0.91	0.82	0.81	0.78	0.80	0.76	0.76	-	0.83
Accounts Receivable Turnover	3.11	3.18	3.22	3.17	3.11	3.40	3.39	3.33	3.26	-	3.31
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Fixed Asset Turnover	7.70	7.62	7.52	7.23	7.31	7.53	7.64	7.75	7.88	-	8.39
Accounts Payable Turnover	12.25	12.49	12.98	15.27	15.64	14.91	10.40	13.99	13.82	-	9.64
Days Sales Outstanding (DSO)	117.27	114.74	113.25	115.12	117.40	107.43	107.61	109.69	111.99	-	110.24
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Days Payable Outstanding (DPO)	29.79	29.23	28.13	23.90	23.34	24.48	35.11	26.09	26.40	-	37.85
Cash Conversion Cycle (CCC)	87.48	85.51	85.12	91.22	94.06	82.95	72.51	83.60	85.59	-	72.39
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	217	169	206	190	191	162	196	196	195	168	220
Invested Capital Turnover	2.79	3.27	2.57	2.72	2.68	3.37	2.78	2.90	2.96	-	2.90
Increase / (Decrease) in Invested Capital	45	9.64	-11	-19	-26	-6.77	-9.35	6.02	4.92	6.24	23
Enterprise Value (EV)	4,163	4,217	4,005	4,616	5,526	4,255	3,671	3,681	3,181	-	3,160
Market Capitalization	4,300	4,404	4,174	4,820	5,745	4,513	3,916	3,913	3,389	-	3,278
Book Value per Share	$6.95	$7.03	$7.34	$7.76	$8.09	$8.29	$8.69	$8.43	$7.98	$7.82	$6.87
Tangible Book Value per Share	$6.79	$6.86	$7.17	$7.59	$7.92	$8.13	$8.52	$8.26	$7.81	$7.65	$6.69
Total Capital	354	356	374	393	410	421	441	428	403	390	338
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-137	-187	-169	-203	-220	-259	-245	-232	-207	-222	-119
Capital Expenditures (CapEx)	3.31	1.93	1.48	1.15	1.71	2.60	1.75	2.27	2.68	2.69	2.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	77	30	70	56	55	25	57	59	55	28	80
Debt-free Net Working Capital (DFNWC)	214	218	238	260	275	284	303	291	262	250	199
Net Working Capital (NWC)	214	218	238	260	275	284	303	291	262	250	199
Net Nonoperating Expense (NNE)	-0.06	-8.13	-7.24	-2.90	-7.31	-3.07	4.71	-14	-6.96	-3.60	-0.67
Net Nonoperating Obligations (NNO)	-137	-187	-169	-203	-220	-259	-245	-232	-207	-222	-119
Total Depreciation and Amortization (D&A)	2.36	2.38	2.32	2.49	2.39	2.49	2.49	2.52	2.53	2.54	2.52
Debt-free, Cash-free Net Working Capital to Revenue	14.15%	5.68%	12.84%	10.38%	10.12%	4.44%	10.27%	10.50%	9.56%	-	13.29%
Debt-free Net Working Capital to Revenue	39.48%	40.54%	44.00%	47.90%	50.46%	50.80%	54.11%	51.86%	45.86%	-	32.96%
Net Working Capital to Revenue	39.48%	40.54%	44.00%	47.90%	50.46%	50.80%	54.11%	51.86%	45.86%	-	32.96%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.48	$0.41	$0.59	$0.57	$0.51	$0.46	$0.52	$0.52	$0.55	$0.49	$0.59
Adjusted Weighted Average Basic Shares Outstanding	51.20M	51.15M	51.01M	51.11M	51.18M	51.13M	51.28M	51.19M	50.87M	50.90M	49.79M
Adjusted Diluted Earnings per Share	$0.48	$0.40	$0.59	$0.57	$0.50	$0.45	$0.52	$0.52	$0.55	$0.48	$0.59
Adjusted Weighted Average Diluted Shares Outstanding	51.65M	51.64M	51.42M	51.52M	51.62M	51.57M	51.65M	51.50M	51.18M	51.24M	50.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	50.62M	50.56M	50.67M	50.73M	50.76M	50.82M	50.75M	50.50M	49.89M	49.25M	48.51M
Normalized Net Operating Profit after Tax (NOPAT)	24	13	23	26	19	21	31	12	21	21	29
Normalized NOPAT Margin	18.36%	10.41%	15.80%	18.73%	13.75%	15.00%	21.55%	8.73%	14.33%	-	17.38%
Pre Tax Income Margin	25.51%	24.48%	27.89%	28.24%	26.37%	22.91%	25.95%	25.93%	26.25%	-	25.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	52.04%	53.86%	54.39%	53.51%	53.73%	53.41%	55.92%	58.36%	58.07%	-	56.69%
Augmented Payout Ratio	82.09%	77.99%	83.66%	82.05%	65.90%	58.64%	56.15%	90.14%	127.43%	-	218.14%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways for Exponent (EXPO) based on the latest four years of quarterly statements, with a focus on the four most recent quarters (Q1–Q4 2025) and relevant context from 2024–2023. The goal is to highlight trends in revenue, profitability, cash flow, and balance-sheet strength for retail investors.

Strong Q4 2025 revenue and profitability: Revenue of $147.43M and net income of $24.76M (EPS around $0.49 basic / $0.48 diluted) in Q4 2025 show continued demand and solid profitability at the end of 2025.
Gross margin expansion in late 2025: Gross profit of $66.53M on $147.43M revenue in Q4 2025 implies a gross margin of about 45%, marking an improvement vs earlier quarters and supporting earnings quality.
Strong operating cash flow in Q4 2025: Net cash from continuing operating activities was $55.58M, underscoring robust cash-generation and operating leverage.
Active capital returns in 2025: In Q4 2025, Exponent repurchased common equity for about $24.38M and paid $14.89M in cash dividends, with a per-share dividend of $0.30, signaling ongoing shareholder value return.
Moderate capex with limited reinvestment: Purchase of property, plant & equipment was modest (~$2.69M in Q4 2025), and investing cash flow was limited, suggesting efficient use of capital and potential for higher FCF in the future.
Gross margin variability across quarters: Q2 2025 gross margin was around 31% (44.49M gross profit on 141.96M revenue), while other quarters in 2025 hovered higher, indicating quarterly mix/pricing shifts that may impact near-term profitability.
Financing outflows reduce cash despite strong ops: Net cash from financing activities remained negative in several 2025 quarters (e.g., around -$38.4M in Q4 2025), reflecting ongoing buybacks and dividends that reduce cash, even as operating cash flow is positive.
Quarterly earnings volatility: While Q3 2025 net income was $28.04M, Q4 2025 declined to $24.76M, suggesting some ebb-and-flow in quarterly earnings that investors should monitor for seasonality or one-off items.
Leverage and liquidity dynamics: Total assets around $760M with liabilities near $359M and equity around $403M in mid-2025 indicate a conservative balance sheet with low debt and solid liquidity, but frequent buybacks reduce equity cushion over time and should be watched if op cash flow weakens.

05/19/26 08:12 PM ETAI Generated. May Contain Errors.

Exponent Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Exponent's fiscal year ends in January. Their fiscal year 2026 ended on January 2, 2026.

Exponent's net income appears to be on an upward trend, with a most recent value of $106.01 million in 2025, rising from $43.60 million in 2015. The previous period was $109.00 million in 2024. See where experts think Exponent is headed by visiting Exponent's forecast page.

Exponent's total operating income in 2025 was $119.79 million, based on the following breakdown:

Total Gross Profit: $240.02 million
Total Operating Expenses: $120.23 million

Over the last 10 years, Exponent's total revenue changed from $312.83 million in 2015 to $582.01 million in 2025, a change of 86.0%.

Exponent's total liabilities were at $387.18 million at the end of 2025, a 8.7% increase from 2024, and a 210.5% increase since 2015.

In the past 10 years, Exponent's cash and equivalents has ranged from $114.97 million in 2016 to $297.69 million in 2021, and is currently $221.93 million as of their latest financial filing in 2025.

Over the last 10 years, Exponent's book value per share changed from 10.21 in 2015 to 7.82 in 2025, a change of -23.3%.

Related Companies

Financial statements for NASDAQ:EXPO last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Financials

Financials Breakdown Chart

Key Financial Trends

Exponent Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exponent (EXPO) Financials

Annual Income Statements for Exponent

Quarterly Income Statements for Exponent

Annual Cash Flow Statements for Exponent

Quarterly Cash Flow Statements for Exponent

Annual Balance Sheets for Exponent

Quarterly Balance Sheets for Exponent

Annual Metrics And Ratios for Exponent

Quarterly Metrics And Ratios for Exponent

Financials Breakdown Chart

Key Financial Trends

Exponent Financials - Frequently Asked Questions

When does Exponent's financial year end?

How has Exponent's net income changed over the last 10 years?

What is Exponent's operating income?

How has Exponent's revenue changed over the last 10 years?

How much debt does Exponent have?

How much cash does Exponent have?

How has Exponent's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools